CD40 and cancer: Our study suggests that in unstimulated cancer cells, CD95 forms a complex comprised of KPC2/KPC1 and p65 that favor the generation of the p50/p50 homodimer at the expense of its pro-inflammatory p50/p65 heterodimer.